a16z Capital Management, L.L.C.
An institutional investment manager in MENLO PARK, CA. Its Form 13F for the quarter ended Jun 30, 2026, filed Aug 14, 2026. SEC CIK 1540358.
- Reported value$14.21bn
- Positions19
Holdings: 19 positions
The filing on sec.govAs filed, largest first. Reported value is what the manager stated for each position at the quarter end, in US dollars; it is filing data, not a price. Weight is the position's share of the total reported value. Changes compare with the 13F for the quarter ended 2026-03-31.
| Issuer | Class | CUSIP | Reported value$bn | Weight | Shares | Put or call | Change on the quarter before |
|---|---|---|---|---|---|---|---|
| Space Exploration Techn CorpSPCX | CLASS A COM STK | 84615Q103 | 12.8 | 90.0% | 74,855,020 | New+74,855,020 | |
| Navan IncNAVN | CL A | 639193101 | 0.6 | 4.5% | 28,218,676 | Unchanged | |
| Revolution Medicines IncRVMD | COM | 76155X100 | 0.2 | 1.2% | 921,099 | Unchanged | |
| Meta Platforms IncMETA | CL A | 30303M102 | 0.1 | 0.8% | 212,531 | Unchanged | |
| Figma IncFIG | CLASS A COM STK | 316841105 | 0.1 | 0.8% | 5,983,308 | Reduced−10,028,070 | |
| Bioage Labs IncBIOA | COM | 09077V100 | 0.1 | 0.6% | 3,233,170 | Unchanged | |
| Block IncXYZ | CL A | 852234103 | 0.1 | 0.5% | 1,016,697 | Unchanged | |
| Erasca IncERAS | COM | 29479A108 | 0.1 | 0.4% | 2,862,500 | Unchanged | |
| Maze Therapeutics IncMAZE | COM | 578784100 | 0.1 | 0.4% | 1,702,225 | Unchanged | |
| Damora Therapeutics Inc | COM NEW | 36322Q206 | 0.0 | 0.2% | 1,236,157 | Unchanged | |
| Omada Health IncOMDA | COM | 68170A108 | 0.0 | 0.2% | 1,153,639 | Reduced−1,153,645 | |
| Nautilus Biotechnology IncNAUT | COM | 63909J108 | 0.0 | 0.1% | 9,063,054 | Reduced−8,590,863 | |
| Roblox CorpRBLX | CL A | 771049103 | 0.0 | 0.1% | 274,570 | New+274,570 | |
| Aktis Oncology IncAKTS | COM | 01021M104 | 0.0 | <0.1% | 415,000 | Unchanged | |
| CAMP4 Therapeutics CorpCAMP | COM | 13463J101 | 0.0 | <0.1% | 2,125,339 | Unchanged | |
| Bitgo Holdings IncBTGO | COM SHS CL A | 091947101 | 0.0 | <0.1% | 666,356 | Unchanged | |
| Kailera Therapeutics IncKLRA | COMMON STOCK | 482931102 | 0.0 | <0.1% | 140,000 | New+140,000 | |
| Ginkgo Bioworks Holdings IncDNA | CL A NEW | 37611X209 | 0.0 | <0.1% | 108,568 | Unchanged | |
| IP Strategy Holdings IncIPST | COM | 42727R302 | 0.0 | <0.1% | 4,137 | New+4,137 |
Sold out: 1 position
Held at the end of the quarter before and not reported this quarter.
| Issuer | Class | CUSIP | Reported value$ | Weight | Shares | Put or call | Change on the quarter before |
|---|---|---|---|---|---|---|---|
| IP Strategy Holdings Inc | COM | 42727R203 | 0.0 | 0.0% | 0 | Sold out−82,740 |
Source: SEC EDGAR, Form 13F-HR, accession 0001540358-26-000010 (on sec.gov). Last ingested by Listed: Oct 22, 2026, 05:26 ET. Listed shows no prices and gives no investment advice.